Carlyle in talks to buy health tech firm Cotiviti for USD 15 billion
Atlanta-based Cotiviti provides payment accuracy and analytics services to health insurers and other healthcare companies.
Hyderabad: Carlyle Group Inc is in talks to buy private healthcare technology firm Cotiviti Inc from Veritas Capital for up to $15 billion, including debt, a person familiar with the matter said.
The private equity firm is looking to partner with another investment firm to pull off the deal, and is also in talks with direct lenders to arrange $5.5 billion of debt financing, according to the person.
If the arrangement goes through, that would be one of the largest ever direct loans, or non-bank buyout loans arranged in the private credit market, according to Bloomberg News, which first reported on the talks.
Atlanta-based Cotiviti provides payment accuracy and analytics services to health insurers and other healthcare companies.
Cotiviti, which went public in 2016, was acquired by Veritas in 2018 in a take-private deal valued at $4.9 billion, as the PE firm looked to expand its Verscend healthcare IT business.
Carlyle, Veritas and Cotiviti did not immediately respond to Reuters requests for comments.
Read also: Carlyle acquires 50 percent stake in Resonetics for USD 2.25 billion: Bloomberg
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd